The surgery was done for a college-aged athlete who had chronic pain from a previous meniscectomy, according to a Feb. 6 news release. RejuvaKnee, developed by Regenity Biosciences, has FDA clearance and has been shown to support a more complete recovery by facilitating regeneration of native meniscus tissue.
Dr. Fleissner plans to perform more meniscus repairs with the implant, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.